Drugs Affecting Cardiac Rhythm

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/48

encourage image

There's no tags or description

Looks like no tags are added yet.

49 Terms

1
New cards

Normal duration of PR interval

120-200 ms

2
New cards

Normal duration of QRS interval

60-100 ms

abnormal if above 120 ms

3
New cards

Normal duration of QT interval

~400 ms

abnormal if below 390 or above 450

4
New cards

a prolonged PR interval is a red flag for

AV conduction issues

5
New cards

A prolonged QT interval is a red flag for

arrhythmia risk (Torsades de pointes)

6
New cards

These classes of antiarrhythmias are mainly for rhythm control// restoring normal sinus rhythm and often lead to what change in the ECG?

  • Class I (Na+ blockers)

  • Class III (K+ blockers)

widen QT interval

7
New cards

These classes of antiarrhythmias are mainly for rate control// restoring normal sinus rhythm and often lead to what change in the ECG?

  • Class II (Beta-blockers)

  • Class IV (Ca2+ blockers)

  • Digoxin

affect the PR interval

8
New cards

Common side effects of Class I antiarrhythmics

proarrhythmic risk

  • quinidine —> cinchonism

  • Torsades de pointes

  • procainamide —> Lupus-like symptoms


9
New cards

Common side effects of Class II antiarrhythmics

  • Bradycardia

  • bronchospasm

  • fatigue


10
New cards

Common side effects of Class III antiarrhythmics

  • Amiodarone → pulmonary toxicity

  • thyroid dysfunction

  • hepatotoxicity

  • blue skin


11
New cards

Common side effects of Class IV antiarrhythmics

  • heart block

  • hypotension


12
New cards

Common side effects of Adenosine as an antiarrhythmic

  • transient asystole

  • flushing

  • chest discomfort


13
New cards

Common contraindications of Class I antiarrhythmics

Avoid class IC (flecainide) in structural heart disease (e.g. heart failure)

14
New cards

Common contraindications of Class II antiarrhythmics

avoid in:

  • asthma

  • severe bradycardia


15
New cards

Common contraindications of Class III antiarrhythmics

Should be avoided in severe lung disease like COPD (e.g. avoid Amiodarone)

16
New cards

Common contraindications of Class IV antiarrhythmics

avoid in:

  • heart failure

  • high-degree AV block

(Ca+ channel blockers selectively affect SA nodal tissue)

17
New cards

Amiodarone has a ______ T1/2 (half-life) such that the patient should _________

LONG (20-100 days); be continuously monitored

18
New cards

Adenosine has a _______ T1/2 (half-life) such that the patient should ________

SHORT (<10 sec); rapidly metabolize the drug

19
New cards

Quinidine (IA):

Oral Bioavailability:

T1/2:

Metabolism/Clearance:

Oral Bioavailability: ~80%

T1/2: 6-8 hrs

Metabolism/Clearance: Hepatic metabolism (CYP3A4)

20
New cards

Lidocaine (IB):

Oral Bioavailability:

T1/2:

Metabolism/Clearance:

Oral Bioavailability: IV → 100% bioavailable

T1/2: 1-2 hrs

Metabolism/Clearance: Hepatic clearance

21
New cards

Flecainide (IC):

Oral Bioavailability:

T1/2:

Metabolism/Clearance:

Oral Bioavailability: ~90%

T1/2: 12-20 hrs

Metabolism/Clearance: Hepatic/Renal Clearance

22
New cards

Metoprolol (II)

Oral Bioavailability:

T1/2:

Metabolism/Clearance:

Oral Bioavailability: ~50%

T1/2: 3-7 hrs

Metabolism/Clearance: Hepatic Metabolism

23
New cards

Verapamil (IV):

Oral Bioavailability:

T1/2:

Metabolism/Clearance:

Oral Bioavailability: ~20-35% (LOW)

T1/2: 3-7 hrs

Metabolism/Clearance: Hepatic Metabolism

24
New cards

Digoxin:

Oral Bioavailability:

T1/2:

Metabolism/Clearance:

Oral Bioavailability: ~70-80%

T1/2: 30-48 hrs

Metabolism/Clearance: N/A

25
New cards

Class IA drugs are for rhythm control in _____________ arrhythmias. An example is _________ for A-fib

Atrial/Ventricular; quinidine

26
New cards

Class IB drugs are for rhythm control in _____________ arrhythmias. Some examples are _________ and _________, usually post-MI

Ventricular; Lidocaine, Mexilitine

27
New cards

Class IC drugs are for rhythm control in _____________ arrhythmias and sustained ventricular tachycardia. An example is _________ for paroxysmal A-fib

Supraventricular arrhythmias; flecainide

28
New cards

Class ID drugs are for rhythm control to suppress ____________, an example is the drug ________

V-Tach; Ranolazine

29
New cards

Class II/IV drugs are for rate control in _______ (arrhythmia type). Examples are _________ and __________

A-Fib; metoprolol and diltiazem

30
New cards

Class III drugs are for rhythm control in _____________ arrhythmias. An example is _________

A-fib/VT; amiodarone

31
New cards

drug that can treat acute SVT

adenosine

32
New cards

drug that slows AV nodal conduction for Afib

Digoxin/Magnesium

33
New cards

Ivabradine (class 0) targets _______________ (arrhythmia/dysfunction) by selectively blocking the If “funny” currents in the SA node

Sinus Tachycardia

34
New cards

Ranolazine (class Id) targets _____________ (arrhythmia/dysfunction) by inhibiting the late inward sodium current (INa,L) - prevents Ca+ overload —> QT prolongation and risk of torsades

Chronic Angina

35
New cards

Adenosine (class IIe) targets _____________ (arrhythmia/dysfunction) by acting as an A1 receptor agonist hyperpolarizing the AV node and causing a transient therapeutic asystole

Acute SVT

36
New cards

Digoxin (class IId) targets _____________ (arrhythmia/dysfunction) by inhibiting Na+/K+ ATPase and enhancing central vagal tone

A-Fib for rate control thereof

37
New cards

Magnesium sulfate (unclassified) targets _____________ (arrhythmia/dysfunction) by blocking Ca+ (naturally) and therefore suppressing early afterdepolarizations

Torsades de Pointes and digitalis-induced arhythmias

38
New cards

Class I antiarrhythmics serve as

sodium channel blockers

target Atrial and Ventricular Muscle (His-Purkinje Fibers)

39
New cards

Class II antiarrhythmics serve as

Beta Receptor Blockers

target SA and AV nodal cells

40
New cards

Class III antiarrhythmics serve as

Potassium Channel Blockers

target AP repolarization - blocking it to extend the QT interval

41
New cards

Class IV antiarrhythmics serve as

Calcium Channel Blockers (Non-Dihydropyridines)

target: SA and AV nodal cells (should not be used in combo w/ Class II (Beta Blockers))

42
New cards

Class Ia

(intermediate)

<p>(intermediate)</p>
43
New cards

Class Ib

(rapid)

<p>(rapid) </p>
44
New cards

Class Ic

(slow)

<p>(slow)</p>
45
New cards

Types of SVT arrhythmias

  • A-Fib/Flutter

    • commonly associated with heart block, 50-250 bpm

    • atria quiver

    • can lead to formation of blood clots in the atria

  • AVNRT (AV nodal reentrant tachycardia) —> e.g. WPW syndrome

  • AVRT (AV reentrant tachycardia) —> often mimics V-tach

  • Junctional Tachycardia —> often seen in digitais toxicity or heart block


46
New cards

indicates a 1st degree heart block

prolongation of PR interval

47
New cards

indicates a 2nd degree heart block

intermittent failure of atrial impulses, dropping of QRS complexes

48
New cards

indicates a 3rd degree heart block

total electrical dissociation between the atria and ventricles

49
New cards

hypokalemia results in ________________ of the heart whereas hyperkalemia results in ___________ of the heart

uncontrolled acceleration of activity; stopping (inactivated Na+ channels due to sustained depolarization)